Correlation Between Scisparc and Pmv Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Scisparc and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scisparc and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Scisparc and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Scisparc and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scisparc with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scisparc and Pmv Pharmaceuticals.

Diversification Opportunities for Scisparc and Pmv Pharmaceuticals

0.37

Correlation Coefficient

Scisparc  Pmv Pharmaceuticals

Weak diversification

The 3 months correlation between Scisparc and Pmv is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Scisparc and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Scisparc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scisparc are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Scisparc i.e., Scisparc and Pmv Pharmaceuticals go up and down completely randomly.

Pair Corralation between Scisparc and Pmv Pharmaceuticals

Given the investment horizon of 90 days Scisparc is expected to generate 6.08 times more return on investment than Pmv Pharmaceuticals. However, Scisparc is 6.08 times more volatile than Pmv Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about -0.17 per unit of risk. If you would invest  47.00  in Scisparc on December 28, 2024 and sell it today you would lose (16.20) from holding Scisparc or give up 34.47% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Scisparc  vs.  Pmv Pharmaceuticals

Scisparc

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Scisparc are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Scisparc exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pmv Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pmv Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Scisparc and Pmv Pharmaceuticals

The main advantage of trading using opposite Scisparc and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scisparc position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.

The idea behind Scisparc and Pmv Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.